Pretreatments of the Skin Prior to PDT
NCT02372370 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2015-02-26
Summary
The study investigates the potential of a range of different physical pretreatments to enhance methyl aminolevulinate (MAL)-induced protoporphyrin IX (PpIX) in the skin prior to photodynamic therapy (PDT).
Conditions
- Healthy
Interventions
- PROCEDURE
-
Microneedle pretreatment + MAL-PDT
Interventions: microneedling of the skin using dermarollers prior to topical application of 125 microliter methyl aminolevulinate (MAL) cream followed by red light illumination after 3 hours incubation (i.e. photodynamic therapy (PDT)). Three settings are applied: mild, moderate and strong.
- PROCEDURE
-
Sandpaper pretreatment + MAL-PDT
Interventions: abrasion of the skin using Abrasive Pads for Skin Preparation prior to topical application of 125 microliter methyl aminolevulinate (MAL) cream followed by red light illumination after 3 hours incubation (i.e. photodynamic therapy (PDT)). Three settings are applied: mild, moderate and strong.
- PROCEDURE
-
Curettage pretreatment + MAL-PDT
Interventions: curettage of the skin using a curette prior to topical application of 125 microliter methyl aminolevulinate (MAL) cream followed by red light illumination after 3 hours incubation (i.e. photodynamic therapy (PDT)). Three settings are applied: mild, moderate and strong.
- PROCEDURE
-
Ablative Fractional Laser (AFXL) pretreatment + MAL-PDT
Interventions: Ablative Fractional Laser (AFXL) resurfacing of the skin prior to topical application of 125 microliter methyl aminolevulinate (MAL) cream followed by red light illumination after 3 hours incubation (i.e. photodynamic therapy (PDT)). Three settings are applied: mild, moderate and strong.
- PROCEDURE
-
Non-Ablative Fractional Laser (NAFXL) pretreatment + MAL-PDT
Interventions: Non-Ablative Fractional Laser (NAFXL) resurfacing of the skin prior to topical application of 125 microliter methyl aminolevulinate (MAL) cream followed by red light illumination after 3 hours incubation (i.e. photodynamic therapy (PDT)). Three settings are applied: mild, moderate and strong.
- DRUG
-
MAL Control.
Intervention: Topical application of 125 microliter methyl aminolevulinate (MAL) cream followed by red light illumination after 3 hours incubation (i.e. photodynamic therapy (PDT)).
- OTHER
-
Untreated Control
Untreated control. No interventions.
Sponsors & Collaborators
-
Bispebjerg Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2014-12-31
- Completion
- 2014-12-31
More Related Trials
-
Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
NCT03013647 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of Topical Calcipotriol-assisted AFL-PDT in Actinic Keratosis
NCT02976727 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1)
NCT01682811 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomized Multicenter Study of Daylight Mediated Photodynamic Therapy (PDT)
NCT00711178 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Treatment of Actinic Keratoses With Photodynamic Therapy Between MAL Cream and ALA Gel
NCT02647151 ·Status: UNKNOWN ·Phase: PHASE4
-
Photodynamic Therapy (PDT) Effect on Large Surface Photodamaged Skin
NCT00843323 ·Status: COMPLETED ·Phase: NA
-
Protocols for Painless Photodynamic Therapy (PDT) of Actinic Keratoses
NCT02124733 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of White-light and Daylight Topical Methyl 5-aminolaevulinic Acid Photodynamic Therapy for Actinic Keratoses
NCT02520700 ·Status: COMPLETED ·Phase: NA
-
Photodynamic Therapy in Treating Patients With Skin Cancer
NCT00002975 ·Status: COMPLETED ·Phase: PHASE2
-
Photodynamic Treatment of Actinic Keratoses With Different Light Doses
NCT01541228 ·Status: COMPLETED ·Phase: NA
-
Transepidermal Application of Metilaminolevulinate in Daylight PDT in the Treatment of Photodamaged Skin
NCT03963765 ·Status: COMPLETED ·Phase: NA
-
Study of Methyl Aminolaevulinate Photodynamic Therapy With and Without Er:YAG Laser in Bowen's Disease
NCT01912976 ·Status: COMPLETED ·Phase: PHASE1
-
Daylight Photodynamic Therapy for the Treatment of Actinic Keratoses in the Northeast United States
NCT02867722 ·Status: WITHDRAWN ·Phase: NA
-
Laser and Microdermabrasion Before Photodynamic Therapy for Actinic Keratoses in Field-cancerized Skin
NCT03006185 ·Status: COMPLETED ·Phase: PHASE2
-
Menthol for PDT Pain Relief
NCT02984072 ·Status: COMPLETED ·Phase: PHASE4
-
Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL
NCT02149342 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma
NCT00469417 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of AFL-assisted PDT With Short Incubation Time in Actinic Keratosis
NCT02248298 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison Between 5-aminolevulinic Acid Photodynamic Therapy Versus Cryotherapy for Actinic Keratosis Treatment
NCT01459393 ·Status: COMPLETED ·Phase: PHASE3
-
Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
NCT03012009 ·Status: COMPLETED ·Phase: NA
-
Photodynamic Therapy of Actinic Keratosis of the Face and Scalp With and Without Prior Curettage
NCT03697590 ·Status: COMPLETED ·Phase: PHASE4
-
PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma
NCT00472043 ·Status: COMPLETED ·Phase: PHASE3
-
Photodynamic Therapy for Benign Dermal Neurofibromas- Phase II
NCT02728388 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison of Two Modes of Photodynamic Therapy for the Treatment of Actinic Keratosis on the Upper Extremities
NCT05359419 ·Status: UNKNOWN ·Phase: PHASE4
-
PD P 506 A-PDT Versus Placebo-PDT and Cryosurgery for the Treatment of AK
NCT00308867 ·Status: COMPLETED ·Phase: PHASE3